NVS
Novartis AG
Stock
$141.00−0.05 (−0.04%)Close Oct 2, 2026
Balance sheet
| Line | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $11.4B | $11.5B | $13.4B | $7.5B | $12.4B | $9.7B | $11.1B | $13.3B | $8.9B | $7.0B |
| Inventory | $6.3B | $5.7B | $5.9B | $7.2B | $6.7B | $7.1B | $6.0B | $7.0B | $6.9B | — |
| Current assets | $30.5B | $29.7B | $30.5B | $36.9B | $45.7B | $29.7B | $29.5B | $35.6B | $28.2B | — |
| Goodwill | $25.6B | $24.8B | $23.3B | $29.3B | $29.6B | $30.0B | $26.5B | $35.3B | $31.8B | — |
| Intangible assets | $29.4B | $26.9B | $26.9B | $31.6B | $34.2B | $36.8B | $28.8B | $38.7B | $30.0B | — |
| Total assets | $110.9B | $102.2B | $99.9B | $117.5B | $131.8B | $127.8B | $118.4B | $145.6B | $133.1B | — |
| Current liabilities | $27.3B | $28.7B | $26.4B | $28.7B | $30.2B | $33.1B | $28.3B | $29.6B | $23.4B | — |
| Total liabilities | $64.4B | $58.1B | $53.2B | $58.0B | $64.0B | $71.1B | $62.8B | $66.9B | $58.8B | — |
| Shareholders' equity | $46.1B | $44.0B | $46.7B | $59.3B | $67.7B | $56.6B | $55.5B | $78.6B | $74.3B | $74.9B |
| Shares outstanding | 1.91B | 1.98B | 2.04B | 2.12B | 2.23B | 2.26B | 2.27B | 2.31B | — | — |
| Current ratio | 1.12 | 1.04 | 1.16 | 1.29 | 1.51 | 0.90 | 1.04 | 1.20 | 1.21 | — |